LY2775240

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY2775240, covering 2017-11-07 to 2017-11-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY2775240 in Healthy Participants [Phase 1]